| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
| GLI family zinc finger 3 | 5 | 0 | 0 | 5 |
| AR protein | 6 | 0 | 0 | 6 |
| nuclear receptor subfamily 1, group I, member 3 | 5 | 0 | 0 | 5 |
| glucocorticoid receptor [Homo sapiens] | 7 | 0 | 0 | 7 |
| retinoid X nuclear receptor alpha | 4 | 0 | 0 | 4 |
| pregnane X nuclear receptor | 4 | 0 | 0 | 4 |
| cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
| DNA polymerase beta | 1 | 0 | 0 | 1 |
| short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 9 | 0 | 10 |
| ATP-binding cassette sub-family C member 3 | 0 | 4 | 0 | 4 |
| Multidrug resistance-associated protein 4 | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| Bile salt export pump | 0 | 7 | 0 | 7 |
| Muscarinic acetylcholine receptor M2 | 0 | 2 | 1 | 6 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M1 | 0 | 3 | 1 | 6 |
| Muscarinic acetylcholine receptor M3 | 0 | 3 | 1 | 6 |
| Muscarinic acetylcholine receptor M4 | 0 | 3 | 1 | 6 |
| Muscarinic acetylcholine receptor M5 | 0 | 3 | 1 | 6 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M2 | 0 | 3 | 1 | 7 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 1 | 6 |
| Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 1 | 5 |
| Alpha-1D adrenergic receptor | 0 | 4 | 1 | 5 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 2 | 0 | 0 | 3 |
| 5-hydroxytryptamine receptor 7 | 0 | 4 | 0 | 4 |
| Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor | 0 | 1 | 1 | 2 |
| Canalicular multispecific organic anion transporter 1 | 0 | 4 | 0 | 4 |
| Chain A, Beta-lactamase | 2 | 0 | 0 | 2 |
| acetylcholinesterase | 2 | 0 | 0 | 2 |
| RAR-related orphan receptor gamma | 5 | 0 | 0 | 5 |
| USP1 protein, partial | 4 | 0 | 0 | 4 |
| TDP1 protein | 5 | 0 | 0 | 5 |
| thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
| retinoic acid nuclear receptor alpha variant 1 | 5 | 0 | 0 | 5 |
| estrogen-related nuclear receptor alpha | 4 | 0 | 0 | 4 |
| estrogen nuclear receptor alpha | 5 | 0 | 0 | 5 |
| IDH1 | 4 | 0 | 0 | 4 |
| euchromatic histone-lysine N-methyltransferase 2 | 4 | 0 | 0 | 4 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 4 | 0 | 0 | 4 |
| thyroid hormone receptor beta isoform a | 4 | 0 | 0 | 4 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 4 | 0 | 0 | 4 |
| mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
| geminin | 4 | 0 | 0 | 4 |
| Vpr | 1 | 0 | 0 | 1 |
| lamin isoform A-delta10 | 4 | 0 | 0 | 4 |
| Bile salt export pump | 0 | 1 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Major prion protein | 0 | 0 | 1 | 1 |
| Cellular tumor antigen p53 | 3 | 0 | 0 | 3 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C9 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 0 | 1 | 1 |
| Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 2 |
| Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 2 | 0 | 2 |
| Sodium channel protein type 9 subunit alpha | 0 | 2 | 0 | 2 |
| Frizzled-8 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 4 | 0 | 1 | 0 | 1 |
| Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
| Chain A, Cruzipain | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 2 | 0 | 0 | 2 |
| regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
| cytochrome P450 2D6 | 3 | 0 | 0 | 3 |
| Beta-1 adrenergic receptor | 0 | 0 | 1 | 1 |
| arylsulfatase A | 1 | 0 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
| cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
| cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
| cytochrome P450 2C9 precursor | 2 | 0 | 0 | 2 |
| muscarinic acetylcholine receptor M1 | 3 | 0 | 0 | 3 |
| Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 3 | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 2 | 2 | 4 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 2 | 1 | 3 |
| Alpha-1A adrenergic receptor | 0 | 0 | 1 | 1 |
| Alpha-2C adrenergic receptor | 0 | 2 | 1 | 3 |
| D | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
| Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
| D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 0 | 2 |
| Adenosine receptor A2b | 0 | 0 | 1 | 1 |
| Adenosine receptor A2a | 0 | 0 | 1 | 1 |
| Alpha-2B adrenergic receptor | 0 | 0 | 0 | 1 |
| D(4) dopamine receptor | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 4 | 1 | 7 |
| Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-1B adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
| Spike glycoprotein | 1 | 0 | 1 | 2 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 5 | 1 | 7 |
| Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
| Nischarin | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 1 | 0 | 5 | 0 | 6 |
| Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
| Nischarin | 0 | 1 | 0 | 1 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 2 | 0 | 0 | 2 |
| Luciferase | 2 | 0 | 0 | 2 |
| interleukin 8 | 2 | 0 | 0 | 2 |
| endonuclease IV | 1 | 0 | 0 | 1 |
| PAX8 | 0 | 0 | 0 | 1 |
| thioredoxin reductase | 2 | 0 | 0 | 2 |
| pregnane X receptor | 3 | 0 | 0 | 3 |
| hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
| ATAD5 protein, partial | 2 | 0 | 0 | 2 |
| Fumarate hydratase | 2 | 0 | 0 | 2 |
| PPM1D protein | 2 | 0 | 0 | 2 |
| Thrombopoietin | 2 | 0 | 0 | 2 |
| Smad3 | 2 | 0 | 0 | 2 |
| estrogen receptor 2 (ER beta) | 2 | 0 | 0 | 2 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 2 | 0 | 0 | 2 |
| farnesoid X nuclear receptor | 4 | 0 | 0 | 4 |
| polyprotein | 2 | 0 | 0 | 2 |
| 67.9K protein | 2 | 0 | 0 | 2 |
| glucocerebrosidase | 1 | 0 | 0 | 1 |
| peroxisome proliferator-activated receptor delta | 2 | 0 | 0 | 2 |
| peroxisome proliferator activated receptor gamma | 3 | 0 | 0 | 3 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 3 | 0 | 0 | 3 |
| aryl hydrocarbon receptor | 3 | 0 | 0 | 3 |
| activating transcription factor 6 | 2 | 0 | 0 | 2 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 2 | 0 | 0 | 2 |
| nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
| nuclear receptor subfamily 0 group B member 1 | 0 | 1 | 0 | 1 |
| cellular tumor antigen p53 isoform a | 2 | 0 | 0 | 2 |
| chromobox protein homolog 1 | 3 | 0 | 0 | 3 |
| thyroid hormone receptor beta isoform 2 | 4 | 0 | 0 | 4 |
| atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
| flap endonuclease 1 | 1 | 0 | 0 | 1 |
| ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
| steroidogenic factor 1 | 0 | 1 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 5 | 0 | 0 | 5 |
| peripheral myelin protein 22 | 1 | 0 | 0 | 1 |
| cytochrome P450 3A4 isoform 1 | 3 | 0 | 0 | 3 |
| muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
| caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
| lethal factor (plasmid) | 2 | 0 | 0 | 2 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 3 | 0 | 0 | 3 |
| Voltage-dependent calcium channel gamma-2 subunit | 2 | 0 | 0 | 2 |
| Interferon beta | 3 | 0 | 0 | 3 |
| Tubulin alpha-1A chain | 0 | 2 | 1 | 3 |
| Tubulin beta chain | 0 | 2 | 1 | 3 |
| Plasma kallikrein | 0 | 0 | 0 | 1 |
| Tubulin beta-4A chain | 0 | 2 | 2 | 5 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Tubulin beta chain | 0 | 2 | 2 | 5 |
| ATP-dependent translocase ABCB1 | 0 | 4 | 0 | 6 |
| Cytochrome P450 3A4 | 0 | 2 | 1 | 3 |
| Tubulin alpha-3C chain | 0 | 2 | 2 | 5 |
| Serine/threonine-protein kinase pim-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit delta | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 3 | 0 | 0 | 3 |
| Glutamate receptor 2 | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 3 | 0 | 0 | 3 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 3 | 0 | 0 | 3 |
| Nuclear receptor ROR-gamma | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 3 | 0 | 0 | 3 |
| Tubulin alpha-1B chain | 0 | 2 | 2 | 5 |
| Tubulin alpha-4A chain | 0 | 2 | 2 | 5 |
| Tubulin beta-4B chain | 0 | 2 | 2 | 5 |
| Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
| Tubulin beta-3 chain | 0 | 2 | 2 | 5 |
| Tubulin beta-2A chain | 0 | 2 | 2 | 5 |
| Tubulin polymerization-promoting protein | 0 | 0 | 1 | 1 |
| Tubulin beta-8 chain | 0 | 2 | 2 | 5 |
| Tubulin beta-2B chain | 0 | 2 | 0 | 2 |
| Tubulin alpha-3E chain | 0 | 2 | 2 | 5 |
| Tubulin alpha-1A chain | 0 | 2 | 2 | 5 |
| Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
| Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
| GABA theta subunit | 3 | 0 | 0 | 3 |
| CREB-binding protein | 1 | 0 | 0 | 1 |
| ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
| Ataxin-2 | 2 | 0 | 0 | 2 |
| Tubulin alpha-1C chain | 0 | 2 | 2 | 5 |
| Tubulin beta-6 chain | 0 | 2 | 2 | 5 |
| Tubulin beta-2B chain | 0 | 2 | 2 | 5 |
| Gamma-aminobutyric acid receptor subunit epsilon | 3 | 0 | 0 | 3 |
| Tubulin beta-1 chain | 0 | 2 | 2 | 5 |
| ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
| Chain A, HADH2 protein | 1 | 0 | 0 | 1 |
| Chain B, HADH2 protein | 1 | 0 | 0 | 1 |
| NFKB1 protein, partial | 1 | 0 | 0 | 1 |
| GALC protein | 1 | 0 | 0 | 1 |
| progesterone receptor | 2 | 0 | 0 | 2 |
| nonstructural protein 1 | 1 | 0 | 0 | 1 |
| G | 1 | 0 | 0 | 1 |
| thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
| heat shock protein beta-1 | 1 | 0 | 0 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
| survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 3 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
| Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
| Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
| Mineralocorticoid receptor | 0 | 0 | 1 | 1 |
| Androgen receptor | 0 | 1 | 0 | 1 |
| C-8 sterol isomerase | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 2 | 0 | 2 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 2 | 0 | 4 | 0 | 4 |
| cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
| glp-1 receptor, partial | 1 | 0 | 0 | 1 |
| aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
| EWS/FLI fusion protein | 2 | 0 | 0 | 2 |
| P53 | 1 | 0 | 0 | 1 |
| RPL19A | 0 | 0 | 1 | 1 |
| Histone H2A.x | 1 | 0 | 0 | 1 |
| Spike glycoprotein | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
| urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
| plasminogen precursor | 1 | 0 | 0 | 1 |
| urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
| nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 1 | 0 | 1 |
| COUP transcription factor 2 isoform a | 0 | 1 | 0 | 1 |
| Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
| Glucose transporter | 0 | 1 | 0 | 1 |
| Hexose transporter 1 | 0 | 1 | 0 | 1 |
| Procathepsin L | 0 | 0 | 1 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 1 | 0 | 1 |
| Alpha-synuclein | 1 | 0 | 0 | 1 |
| Eukaryotic initiation factor 4A-I | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 2 | 0 | 2 |
| Peptidyl-prolyl cis-trans isomerase FKBP3 | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP4 | 0 | 1 | 0 | 1 |
| TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 1 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha | 0 | 1 | 0 | 1 |
| Endothelial PAS domain-containing protein 1 | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP14 | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 | 0 | 1 | 0 | 1 |
| heat shock protein 90, putative | 0 | 0 | 0 | 1 |
| thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
| Bloom syndrome protein isoform 1 | 1 | 0 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
| Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Opioid receptor homologue | 0 | 1 | 0 | 1 |
| Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
| Translocator protein | 0 | 0 | 1 | 1 |
| Histidine decarboxylase | 0 | 0 | 2 | 2 |
| Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 4 | 2 | 7 |
| Kappa-type opioid receptor | 0 | 4 | 2 | 7 |
| Mu-type opioid receptor | 0 | 4 | 2 | 9 |
| Kappa-type opioid receptor | 0 | 4 | 2 | 7 |
| Mu-type opioid receptor | 0 | 4 | 3 | 10 |
| UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
| Delta-type opioid receptor | 0 | 4 | 3 | 10 |
| Kappa-type opioid receptor | 0 | 4 | 0 | 5 |
| Kappa-type opioid receptor | 0 | 4 | 2 | 10 |
| Mu-type opioid receptor | 0 | 4 | 2 | 9 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3E | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D6 | 0 | 3 | 0 | 4 |
| UDP-glucuronosyltransferase 1A1 | 0 | 0 | 0 | 1 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3D | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3C | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Histidine-rich protein PFHRP-II | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |